- PacRoots Cannabis employs genetic modification to customize cannabis strains in bid to enhance product potency, quality
- Company has strategic licensing agreement with Phenome One, a bio-tech firm boasting a database of over 350 unique live cannabis strains
- Partnership allows PacRoots ability to optimize genetic makeup of its cannabis crop based upon plant’s intended end use
- Use of genetic modification can also help companies cultivate plants which are better suited towards overall yield enhancement, thereby boosting overall profit margins
In the late 1860s, Friar Gregor Mendel, an Augustinian monk and scientist living in a monastery in the depths of the Austrian empire, set about cross-breeding different species of garden pea plants – an experiment which would ultimately plant the seed for genetic modifications in modern agriculture. Over 150 years later, the cannabis industry is picking up from where Friar Mendel left off. PacRoots Cannabis (CSE: PACR), a Canada-based company, has sought to adopt a genetics-focused approach towards producing premium quality cannabis products—positioning itself to become a trailblazer in providing industry-leading strains not currently available in the regulated market.
PacRoots expects to be cash flow positive within its first year of trading following the sales from the 100-acre Hemp Project, in Rock Creek, BC. The company has embraced Phenome One’s growing IP, methods and systems; including systematic planting of young hardy plants in rows vs a seed spread, advanced weed suppression and a rigorous nutrient formulae and irrigation regime that will drive quality and yield (http://cnw.fm/66P9w).
As part of the agreement, PacRoots Cannabis will gain access to Phenome One’s database of over 350 unique, live cannabis strains, which have been carefully field-tested and artificially selected over 30 years of research. Acquiring the ability to optimize the genetic makeup of its cannabis plants will enable PacRoots Cannabis to not only develop unique strains featuring a variety of beneficial characteristics but also enhance the potency, bud quality and overall yield of its plants.
“This is a major opportunity for PacRoots to be positioned to offer customers an extensive collection of cannabis cultivars,” said PacRoots CEO and President Patrick Elliot. “At PacRoots, we pride ourselves and our customers with quality and we are thrilled with the opportunity to partner with Phenome One, establishing a robust cultivar portfolio that compares favorably over others in the Canadian cannabis space” (http://cnw.fm/fyPFl).
The use of artificial selection and marker-assisted breeding has enabled cannabis cultivators to optimize the size, color, smell, density and texture of the resulting cannabis crop – thereby allowing for particular strains to be customized depending on their end-use. Whether it be proprietary high-THC strains, cannabidiol-dominant strains with rare terpene profiles, or custom strains finely tailored for medical purposes (http://cnw.fm/sJRmi), the ability to visualize, control and potentially modify the genetic structure of their marijuana plants allow cannabis companies to maximize the quality of their products. Moreover, the use of genetic modifications has allowed companies to boost the overall profitability of their businesses by enhancing plant yields – for instance, selecting genetic makeups which result in larger and more numerous buds on each plant can help PacRoots Cannabis ultimately grow more cannabis per grow light.
“You can get more yield off of a plant if you can refine the genetics and that allows us to have more grams, more kilograms coming out of this place per year,” explained Canopy Growth’s Vice President of communications Jordan Sinclair during a 2019 interview at the company’s Tweed Farms operations (http://cnw.fm/v5nOH).
With the use of cannabis-based products gaining increasing prominence and acceptance across wide swaths of society, the need to enhance and differentiate cannabis products through their genetic makeup is rapidly becoming a priority for cultivators in the sector. Through its pioneering approach towards producing premium-grade cannabis strains, and following its tie-up with Phenome One, PacRoots Cannabis is well on its way towards creating a unique foothold for itself within the global cannabis industry.
For more information, visit the company’s website at www.PacRoots.ca.
NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.